Status:
COMPLETED
Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
COVID-19
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Severe COVID-19 patients at a high risk of venous thromboembolism. We studied patients in 2 intensive care units of university hospitals in Barcelona and Badalona, Spain. We performed a cut-off screen...
Detailed Description
SARS-CoV-2 infection has been associated with coagulation disorders and increased risk of venous thromboembolism (VTE). The aim of the study is to determine the cumulative incidence of VTE in critical...
Eligibility Criteria
Inclusion
- Patients with severe COVID-19 pneumonia admitted to the intensive care unit
Exclusion
- Treatment with Extracorporeal membrane oxygenation (ECMO)
- Pregnant or postpartum women
- Under 18 years old
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04374617
Start Date
April 1 2020
End Date
May 1 2020
Last Update
May 6 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Vall d´Hebron Research Institute VHIR
Barcelona, Catalonia, Spain, 08035
2
Hospital Germans Trias i Pujol. Universitat Autònoma de Barcelona
Badalona, Spain, 08916
3
Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
Barcelona, Spain, 08035